Abstract:Background: Long non-coding RNAs function as competing endogenous RNAs (ceRNAs). Whether growth arrest-specific transcript 5 (GAS5) acts as a ceRNA for microRNA-222 in liver fibrosis remains undefined. Results: GAS5 increases p27 expression as a ceRNA for microRNA-222, thereby inhibiting liver fibrosis progression. Conclusion: The GAS5/microRNA-222/p27 axis underlies the pathogenesis of liver fibrosis. Significance: The ceRNA network helps to understand liver fibrogenesis. Effective control of hepatic stellate cell (HSC) activation and proliferation is critical to the treatment of liver fibrosis. Long non-coding RNAs have been shown to play a pivotal role in the regulation of cellular processes. It has been reported that growth arrest-specific transcript 5 (GAS5) acts as a crucial mediator in the control of cell proliferation and growth. However, little is known about the role and underlying mechanism of GAS5 in liver fibrosis. In this study, our results indicated that GAS5 expression was reduced in mouse, rat, and human fibrotic liver samples and in activated HSCs. Overexpression of GAS5 suppressed the activation of primary HSCs in vitro and alleviated the accumulation of collagen in fibrotic liver tissues in vivo. We identified GAS5 as a target of microRNA-222 (miR-222) and showed that miR-222 could inhibit the expression of GAS5. Interestingly, GAS5 could also repress miR-222 expression. A pulldown assay further validated that GAS5 could directly bind to miR-222. As a competing endogenous RNAs, GAS5 had no effect on primary miR-222 expression. In addition, GAS5 was mainly localized in the cytoplasm. Quantitative RT-PCR further demonstrated that the copy numbers of GAS5 per cell are higher than those of miR-222. GAS5 increased the level of p27 protein by functioning as a competing endogenous RNA for miR-222, thereby inhibiting the activation and proliferation of HSCs. Taken together, a new regulatory circuitry in liver fibrosis has been identified in which RNAs cross-talk by competing for shared microRNAs. Our findings may provide a new therapeutic strategy for liver fibrosis.

Mitochondrial long non-coding RNA GAS5 tunes TCA metabolism in response to nutrient stress

The Landscape of Subcellular Long Non-coding RNAs Links Organelle Metabolic Homeostasis

Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis Through a Mechanism of Competing Endogenous RNA*

Long non-coding RNA GAS5 in human cancer

The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers

The Mechanisms of Lncrna GAS5 in Cardiovascular Cells and Its Potential As Novel Therapeutic Target

Long Non‑coding RNA GAS5 in Human Cancer (Review)

A Critical Role for the Long Non‐coding RNA GAS5 in Proliferation and Apoptosis in Non‐small‐cell Lung Cancer

Long non-coding RNA growth arrest specific transcript 5 acts as a tumour suppressor in colorectal cancer by inhibiting interleukin-10 and vascular endothelial growth factor expression

LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis

Mitochondrial Elongation-Mediated Glucose Metabolism Reprogramming is Essential for Tumour Cell Survival During Energy Stress.

How long noncoding RNAs enforce their will on mitochondrial activity: regulation of mitochondrial respiration, reactive oxygen species production, apoptosis, and metabolic reprogramming in cancer

Upregulation Of Long Noncoding Rna Gas5 Inhibits Lung Cancer Cell Proliferation And Metastasis Via Mir-205/Pten Axis

LncND5 encoded by mitochondrial genomes regulating mitochondrial autophagy via activation of complex Ⅰ and binding to HMGCS1

Long Noncoding RNA GAS5 Accelerates Cholangiocarcinoma Progression by Regulating hsa-miR-1297

Long Stress-Induced Non-Coding Transcript 5: A Promising Therapeutic Target for Cancer Treatment

Nuclear-Encoded Lncrna MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells Through the Mitophagy Pathway

LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway

Nuclear-encoded lncRNA MALAT1 epigenetically controls metabolic reprogramming in hepatocellular carcinoma cells through the mitophagy pathway

The role of long non-coding RNA GAS5 in cancers

Mitochondria-localized Cgas Suppresses Ferroptosis to Promote Cancer Progression.